TRMK(TRMK)
TRMK
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $845M | $885M |
| Low | $839M | $876M |
| High | $850M | $892M |
| EBITDA Avg | $198M | $208M |
| Low | $197M | $206M |
| High | $199M | $209M |
| EBIT Avg | $153M | $160M |
| Low | $152M | $158M |
| High | $154M | $161M |
| Net Income Avg | $237M | $248M |
| Low | $236M | $242M |
| High | $239M | $254M |
| EPS Avg | $3.92 | $4.11 |
| Low | $3.89 | $4.00 |
| High | $3.95 | $4.19 |
| Analysts (Rev / EPS) | 3 / 5 | 3 / 5 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $214M | $216M | $214M | $220M | $224M | $227M |
| Low | $212M | $215M | $213M | $219M | $223M | $226M |
| High | $216M | $217M | $216M | $221M | $226M | $228M |
| EBITDA Avg | $50M | $51M | $50M | $52M | $53M | $53M |
| Low | $50M | $51M | $50M | $51M | $52M | $53M |
| High | $51M | $51M | $51M | $52M | $53M | $54M |
| EBIT Avg | $39M | $39M | $39M | $40M | $41M | $41M |
| Low | $38M | $39M | $39M | $40M | $40M | $41M |
| High | $39M | $39M | $39M | $40M | $41M | $41M |
| Net Income Avg | $58M | $59M | $56M | $60M | $62M | $63M |
| Low | $56M | $58M | $56M | $60M | $62M | $62M |
| High | $60M | $59M | $57M | $61M | $63M | $63M |
| EPS Avg | $0.99 | $1.00 | $0.96 | $1.02 | $1.06 | $1.07 |
| Low | $0.95 | $0.99 | $0.95 | $1.02 | $1.05 | $1.06 |
| High | $1.02 | $1.01 | $0.97 | $1.03 | $1.07 | $1.08 |
| Analysts (Rev / EPS) | 3 / 5 | 3 / 4 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |